SBP Research Inc

Meet Dr. Robert W. Yancey Jr a dedicated M.D. based in Gainesville FL. Specializing in general allopathic medicine Dr. Yancey holds the prestigious title of Medical Doctor signifying his expertise in the broad spectrum of medical care. With a passion for helping patients achieve optimal health Dr. Yancey provides comprehensive medical services with a focus on general health and well-being. Patients can trust in his extensive knowledge and experience in allopathic medicine making him a valued healthcare provider in the Gainesville community. Generated from this place's public information

Outlier Technology LLC is a neuroscience innovation and health longevity company based in Gainesville, FL, dedicated to developing low-cost diagnostic systems and affordable individualized treatment platforms. Their mission focuses on enhancing access to non-invasive screenings for neurological health and facilitating neurorehabilitation through interactive music-based augmented reality interventions. By leveraging the brain's ability to process music across multiple regions, Outlier Technology aims to activate neuroplasticity and improve neural connectivity in individuals diagnosed with neurological disorders. Their creative, cross-disciplinary approach addresses some of today's significant challenges in neuroscience and therapeutics. Generated from the website

RanTran, Inc. is a development-stage company based in Gainesville, FL, dedicated to investigating, developing, and commercializing therapies aimed at combating neurodegenerative diseases, which are among the most devastating health challenges today. The company focuses on groundbreaking research related to repeat-associated non-AUG (RAN) translation, striving to create innovative treatment pathways for conditions such as genetic forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Through the identification and manipulation of pathways that block RAN translation or target RAN proteins, RanTran aims to establish a platform technology that can address C9orf72-related ALS and FTD, as well as a broader range of diseases involving RAN proteins. Their commitment to scientific advancement positions them at the forefront of neurodegenerative disease research and therapy development. Generated from the website